Prevalence of influenza A and B antibodies in pregnant women and their offspring.
Identifieur interne : 000404 ( Main/Exploration ); précédent : 000403; suivant : 000405Prevalence of influenza A and B antibodies in pregnant women and their offspring.
Auteurs : Peter Wutzler [Allemagne] ; Ruprecht Schmidt-Ott ; Heike Hoyer ; Andreas SauerbreiSource :
- Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology [ 1873-5967 ] ; 2009.
Descripteurs français
- KwdFr :
- Adolescent (MeSH), Adulte (MeSH), Allemagne (épidémiologie), Analyse de variance (MeSH), Anticorps antiviraux (sang), Complications infectieuses de la grossesse (immunologie), Complications infectieuses de la grossesse (virologie), Complications infectieuses de la grossesse (épidémiologie), Femelle (MeSH), Grippe humaine (immunologie), Grippe humaine (virologie), Grippe humaine (épidémiologie), Grossesse (MeSH), Humains (MeSH), Immunoglobuline G (sang), Modèles logistiques (MeSH), Nouveau-né (MeSH), Prévalence (MeSH), Virus de la grippe A (immunologie), Virus de la grippe A (isolement et purification), Virus influenza B (immunologie), Virus influenza B (isolement et purification), Études séroépidémiologiques (MeSH).
- MESH :
- immunologie : Complications infectieuses de la grossesse, Grippe humaine, Virus de la grippe A, Virus influenza B.
- isolement et purification : Virus de la grippe A, Virus influenza B.
- sang : Anticorps antiviraux, Immunoglobuline G.
- virologie : Complications infectieuses de la grossesse, Grippe humaine.
- épidémiologie : Allemagne, Complications infectieuses de la grossesse, Grippe humaine.
- Adolescent, Adulte, Analyse de variance, Femelle, Grossesse, Humains, Modèles logistiques, Nouveau-né, Prévalence, Études séroépidémiologiques.
- Wicri :
- geographic : Allemagne.
English descriptors
- KwdEn :
- Adolescent (MeSH), Adult (MeSH), Analysis of Variance (MeSH), Antibodies, Viral (blood), Female (MeSH), Germany (epidemiology), Humans (MeSH), Immunoglobulin G (blood), Infant, Newborn (MeSH), Influenza A virus (immunology), Influenza A virus (isolation & purification), Influenza B virus (immunology), Influenza B virus (isolation & purification), Influenza, Human (epidemiology), Influenza, Human (immunology), Influenza, Human (virology), Logistic Models (MeSH), Pregnancy (MeSH), Pregnancy Complications, Infectious (epidemiology), Pregnancy Complications, Infectious (immunology), Pregnancy Complications, Infectious (virology), Prevalence (MeSH), Seroepidemiologic Studies (MeSH).
- MESH :
- chemical , blood : Antibodies, Viral, Immunoglobulin G.
- geographic , epidemiology : Germany.
- epidemiology : Influenza, Human, Pregnancy Complications, Infectious.
- immunology : Influenza A virus, Influenza B virus, Influenza, Human, Pregnancy Complications, Infectious.
- isolation & purification : Influenza A virus, Influenza B virus.
- virology : Influenza, Human, Pregnancy Complications, Infectious.
- Adolescent, Adult, Analysis of Variance, Female, Humans, Infant, Newborn, Logistic Models, Pregnancy, Prevalence, Seroepidemiologic Studies.
Abstract
BACKGROUND
Influenza is associated with substantial morbidity and mortality in pregnant women and neonates, but few countries offer annual influenza vaccination with the inactivated vaccine to all women who are, or intend to become, pregnant.
OBJECTIVES
To provide seroepidemiological information on influenza A and B antibodies in pregnant women and their offspring in Germany.
STUDY DESIGN
Anti-influenza antibodies were determined using commercially available enzyme-linked immunosorbent assays (ELISA) on serum obtained from 209 women and their newborns at delivery.
RESULTS
The prevalence of antibodies against influenza A virus was 93.8% [89.6-96.6%] in the mothers and 96.7% [93.2-98.6%] in the newborns. The prevalence of antibodies against influenza B virus was 42.1% [35.3-49.1%] in the mothers and 78.5% [72.3-83.8%] in their newborns, which was a significant difference. The antibody concentrations against both influenza A and influenza B viruses were significantly lower in mother than in their newborns.
CONCLUSIONS
Because of active placental transport of IgG antibodies, neonates have higher prevalence and/or concentrations of influenza A and B virus-specific antibodies induced by natural infections than their mothers. Considering these serological findings, especially the lower prevalence of maternal antibody against influenza B virus, annual influenza vaccination may improve the protection of pregnant women and their offspring against influenza.
DOI: 10.1016/j.jcv.2009.06.024
PubMed: 19643662
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Prevalence of influenza A and B antibodies in pregnant women and their offspring.</title><author><name sortKey="Wutzler, Peter" sort="Wutzler, Peter" uniqKey="Wutzler P" first="Peter" last="Wutzler">Peter Wutzler</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Virology and Antiviral Therapy, Friedrich-Schiller University of Jena, Jena, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Institute of Virology and Antiviral Therapy, Friedrich-Schiller University of Jena, Jena</wicri:regionArea><wicri:noRegion>Jena</wicri:noRegion><wicri:noRegion>Jena</wicri:noRegion><wicri:noRegion>Jena</wicri:noRegion></affiliation></author><author><name sortKey="Schmidt Ott, Ruprecht" sort="Schmidt Ott, Ruprecht" uniqKey="Schmidt Ott R" first="Ruprecht" last="Schmidt-Ott">Ruprecht Schmidt-Ott</name></author><author><name sortKey="Hoyer, Heike" sort="Hoyer, Heike" uniqKey="Hoyer H" first="Heike" last="Hoyer">Heike Hoyer</name></author><author><name sortKey="Sauerbrei, Andreas" sort="Sauerbrei, Andreas" uniqKey="Sauerbrei A" first="Andreas" last="Sauerbrei">Andreas Sauerbrei</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2009">2009</date><idno type="RBID">pubmed:19643662</idno><idno type="pmid">19643662</idno><idno type="doi">10.1016/j.jcv.2009.06.024</idno><idno type="wicri:Area/Main/Corpus">000404</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000404</idno><idno type="wicri:Area/Main/Curation">000404</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000404</idno><idno type="wicri:Area/Main/Exploration">000404</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Prevalence of influenza A and B antibodies in pregnant women and their offspring.</title><author><name sortKey="Wutzler, Peter" sort="Wutzler, Peter" uniqKey="Wutzler P" first="Peter" last="Wutzler">Peter Wutzler</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Virology and Antiviral Therapy, Friedrich-Schiller University of Jena, Jena, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Institute of Virology and Antiviral Therapy, Friedrich-Schiller University of Jena, Jena</wicri:regionArea><wicri:noRegion>Jena</wicri:noRegion><wicri:noRegion>Jena</wicri:noRegion><wicri:noRegion>Jena</wicri:noRegion></affiliation></author><author><name sortKey="Schmidt Ott, Ruprecht" sort="Schmidt Ott, Ruprecht" uniqKey="Schmidt Ott R" first="Ruprecht" last="Schmidt-Ott">Ruprecht Schmidt-Ott</name></author><author><name sortKey="Hoyer, Heike" sort="Hoyer, Heike" uniqKey="Hoyer H" first="Heike" last="Hoyer">Heike Hoyer</name></author><author><name sortKey="Sauerbrei, Andreas" sort="Sauerbrei, Andreas" uniqKey="Sauerbrei A" first="Andreas" last="Sauerbrei">Andreas Sauerbrei</name></author></analytic><series><title level="j">Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology</title><idno type="eISSN">1873-5967</idno><imprint><date when="2009" type="published">2009</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent (MeSH)</term><term>Adult (MeSH)</term><term>Analysis of Variance (MeSH)</term><term>Antibodies, Viral (blood)</term><term>Female (MeSH)</term><term>Germany (epidemiology)</term><term>Humans (MeSH)</term><term>Immunoglobulin G (blood)</term><term>Infant, Newborn (MeSH)</term><term>Influenza A virus (immunology)</term><term>Influenza A virus (isolation & purification)</term><term>Influenza B virus (immunology)</term><term>Influenza B virus (isolation & purification)</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (immunology)</term><term>Influenza, Human (virology)</term><term>Logistic Models (MeSH)</term><term>Pregnancy (MeSH)</term><term>Pregnancy Complications, Infectious (epidemiology)</term><term>Pregnancy Complications, Infectious (immunology)</term><term>Pregnancy Complications, Infectious (virology)</term><term>Prevalence (MeSH)</term><term>Seroepidemiologic Studies (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent (MeSH)</term><term>Adulte (MeSH)</term><term>Allemagne (épidémiologie)</term><term>Analyse de variance (MeSH)</term><term>Anticorps antiviraux (sang)</term><term>Complications infectieuses de la grossesse (immunologie)</term><term>Complications infectieuses de la grossesse (virologie)</term><term>Complications infectieuses de la grossesse (épidémiologie)</term><term>Femelle (MeSH)</term><term>Grippe humaine (immunologie)</term><term>Grippe humaine (virologie)</term><term>Grippe humaine (épidémiologie)</term><term>Grossesse (MeSH)</term><term>Humains (MeSH)</term><term>Immunoglobuline G (sang)</term><term>Modèles logistiques (MeSH)</term><term>Nouveau-né (MeSH)</term><term>Prévalence (MeSH)</term><term>Virus de la grippe A (immunologie)</term><term>Virus de la grippe A (isolement et purification)</term><term>Virus influenza B (immunologie)</term><term>Virus influenza B (isolement et purification)</term><term>Études séroépidémiologiques (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Viral</term><term>Immunoglobulin G</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Germany</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term><term>Pregnancy Complications, Infectious</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Complications infectieuses de la grossesse</term><term>Grippe humaine</term><term>Virus de la grippe A</term><term>Virus influenza B</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A virus</term><term>Influenza B virus</term><term>Influenza, Human</term><term>Pregnancy Complications, Infectious</term></keywords><keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Influenza A virus</term><term>Influenza B virus</term></keywords><keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Virus de la grippe A</term><term>Virus influenza B</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps antiviraux</term><term>Immunoglobuline G</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Complications infectieuses de la grossesse</term><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Influenza, Human</term><term>Pregnancy Complications, Infectious</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Allemagne</term><term>Complications infectieuses de la grossesse</term><term>Grippe humaine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Analysis of Variance</term><term>Female</term><term>Humans</term><term>Infant, Newborn</term><term>Logistic Models</term><term>Pregnancy</term><term>Prevalence</term><term>Seroepidemiologic Studies</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Analyse de variance</term><term>Femelle</term><term>Grossesse</term><term>Humains</term><term>Modèles logistiques</term><term>Nouveau-né</term><term>Prévalence</term><term>Études séroépidémiologiques</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Allemagne</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b></p><p>Influenza is associated with substantial morbidity and mortality in pregnant women and neonates, but few countries offer annual influenza vaccination with the inactivated vaccine to all women who are, or intend to become, pregnant.</p></div><div type="abstract" xml:lang="en"><p><b>OBJECTIVES</b></p><p>To provide seroepidemiological information on influenza A and B antibodies in pregnant women and their offspring in Germany.</p></div><div type="abstract" xml:lang="en"><p><b>STUDY DESIGN</b></p><p>Anti-influenza antibodies were determined using commercially available enzyme-linked immunosorbent assays (ELISA) on serum obtained from 209 women and their newborns at delivery.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>The prevalence of antibodies against influenza A virus was 93.8% [89.6-96.6%] in the mothers and 96.7% [93.2-98.6%] in the newborns. The prevalence of antibodies against influenza B virus was 42.1% [35.3-49.1%] in the mothers and 78.5% [72.3-83.8%] in their newborns, which was a significant difference. The antibody concentrations against both influenza A and influenza B viruses were significantly lower in mother than in their newborns.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b></p><p>Because of active placental transport of IgG antibodies, neonates have higher prevalence and/or concentrations of influenza A and B virus-specific antibodies induced by natural infections than their mothers. Considering these serological findings, especially the lower prevalence of maternal antibody against influenza B virus, annual influenza vaccination may improve the protection of pregnant women and their offspring against influenza.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19643662</PMID><DateCompleted><Year>2009</Year><Month>12</Month><Day>22</Day></DateCompleted><DateRevised><Year>2009</Year><Month>09</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-5967</ISSN><JournalIssue CitedMedium="Internet"><Volume>46</Volume><Issue>2</Issue><PubDate><Year>2009</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology</Title><ISOAbbreviation>J. Clin. Virol.</ISOAbbreviation></Journal><ArticleTitle>Prevalence of influenza A and B antibodies in pregnant women and their offspring.</ArticleTitle><Pagination><MedlinePgn>161-4</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcv.2009.06.024</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Influenza is associated with substantial morbidity and mortality in pregnant women and neonates, but few countries offer annual influenza vaccination with the inactivated vaccine to all women who are, or intend to become, pregnant.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To provide seroepidemiological information on influenza A and B antibodies in pregnant women and their offspring in Germany.</AbstractText><AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">Anti-influenza antibodies were determined using commercially available enzyme-linked immunosorbent assays (ELISA) on serum obtained from 209 women and their newborns at delivery.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The prevalence of antibodies against influenza A virus was 93.8% [89.6-96.6%] in the mothers and 96.7% [93.2-98.6%] in the newborns. The prevalence of antibodies against influenza B virus was 42.1% [35.3-49.1%] in the mothers and 78.5% [72.3-83.8%] in their newborns, which was a significant difference. The antibody concentrations against both influenza A and influenza B viruses were significantly lower in mother than in their newborns.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Because of active placental transport of IgG antibodies, neonates have higher prevalence and/or concentrations of influenza A and B virus-specific antibodies induced by natural infections than their mothers. Considering these serological findings, especially the lower prevalence of maternal antibody against influenza B virus, annual influenza vaccination may improve the protection of pregnant women and their offspring against influenza.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wutzler</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institute of Virology and Antiviral Therapy, Friedrich-Schiller University of Jena, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmidt-Ott</LastName><ForeName>Ruprecht</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Hoyer</LastName><ForeName>Heike</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Sauerbrei</LastName><ForeName>Andreas</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2009</Year><Month>07</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Clin Virol</MedlineTA><NlmUniqueID>9815671</NlmUniqueID><ISSNLinking>1386-6532</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000704" MajorTopicYN="N">Analysis of Variance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009980" MajorTopicYN="N">Influenza A virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation & purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009981" MajorTopicYN="N">Influenza B virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation & purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011251" MajorTopicYN="N">Pregnancy Complications, Infectious</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016036" MajorTopicYN="N">Seroepidemiologic Studies</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2008</Year><Month>12</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2009</Year><Month>06</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2009</Year><Month>06</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>8</Month><Day>1</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>8</Month><Day>1</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>12</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19643662</ArticleId><ArticleId IdType="pii">S1386-6532(09)00296-0</ArticleId><ArticleId IdType="doi">10.1016/j.jcv.2009.06.024</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Allemagne</li></country></list><tree><noCountry><name sortKey="Hoyer, Heike" sort="Hoyer, Heike" uniqKey="Hoyer H" first="Heike" last="Hoyer">Heike Hoyer</name><name sortKey="Sauerbrei, Andreas" sort="Sauerbrei, Andreas" uniqKey="Sauerbrei A" first="Andreas" last="Sauerbrei">Andreas Sauerbrei</name><name sortKey="Schmidt Ott, Ruprecht" sort="Schmidt Ott, Ruprecht" uniqKey="Schmidt Ott R" first="Ruprecht" last="Schmidt-Ott">Ruprecht Schmidt-Ott</name></noCountry><country name="Allemagne"><noRegion><name sortKey="Wutzler, Peter" sort="Wutzler, Peter" uniqKey="Wutzler P" first="Peter" last="Wutzler">Peter Wutzler</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeAllemagneV4/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000404 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000404 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeAllemagneV4
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:19643662
|texte= Prevalence of influenza A and B antibodies in pregnant women and their offspring.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:19643662" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeAllemagneV4
| This area was generated with Dilib version V0.6.35. |  |